Merck and Eisai update on Two Phase 3 Trials Evaluating Keytruda plus Lenima for cell lung cancer
The companies will work with investigators to share the results with the scientific community
The companies will work with investigators to share the results with the scientific community
Alleviating staff shortages by empowering surgeons with greater personalization and control
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
Meningitis still affects more than 2.5 million people globally each year
Pirfenidone Capsules had estimated annual sales of USD 95 million in the US
This product will be manufactured at Lupin's Pithampur facility in India
Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026
First of its kind screening for Glaucoma at grass root level over 10k screened already
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
Decisions on the marketing authorization for Rystiggo in the European and Japanese markets are expected in Q1 of 2024
Subscribe To Our Newsletter & Stay Updated